Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biocompatibility and extracorporeal circulation]

M Camici1

  • 1Istituto di Clinica Medica II, Università degli Studi di Pisa.

La Clinica Terapeutica
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ocular involvement in monkeypox: Description of an unusual presentation during the current outbreak.

The Journal of infection·2022
Same author

A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017
Same author

Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.

The international journal of biochemistry & cell biology·2015
Same author

The purine analog fludarabine acts as a cytosolic 5'-nucleotidase II inhibitor.

Biochemical pharmacology·2015
Same author

Partial purification and characterization of a proteolytic activity of alfalfa juice.

Journal of agricultural and food chemistry·2009
Same author

The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme.

The international journal of biochemistry & cell biology·2009
Same journal

Effectiveness of Focal Muscle Vibration in Post-Anterior Cruciate Ligament Reconstruction Rehabilitation: A Case Report.

La Clinica terapeutica·2026
Same journal

Violence Against Women as a Public-Health Exposure: Biological Embedding, Medico-Legal Caution and Precision Prevention in the EpiWe Framework.

La Clinica terapeutica·2026
Same journal

Suicide of the Work-Disabled Individual Affected by Neoplasia with Unfavorable Prognosis: Evidence-Based Legal Medicine in Reconstructing the Causal Link.

La Clinica terapeutica·2026
Same journal

The therapeutic potential of N-acetylcysteine across multiple organ systems: a narrative review.

La Clinica terapeutica·2026
Same journal

Mesotherapy in Pain Management in Primary Care: A Narrative Review and Practice-Oriented Appraisal.

La Clinica terapeutica·2026
Same journal

Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative Review.

La Clinica terapeutica·2026
See all related articles

Biocompatibility in hemodialysis impacts blood clotting and dialytic efficiency. Continuous prostacyclin infusion may improve outcomes by managing platelet activation and coagulation.

Area of Science:

  • Biomedical Engineering
  • Nephrology
  • Hematology

Context:

  • Extracorporeal circulation, particularly hemodialysis, necessitates understanding biomaterial interactions.
  • Membrane biocompatibility is crucial for patient safety and treatment efficacy.
  • Existing knowledge on hemodialysis biocompatibility requires synthesis and clinical correlation.

Purpose:

  • To analyze the clinical implications of membrane biocompatibility during hemodialysis.
  • To investigate the effects of platelet activation on coagulation and dialytic efficiency.
  • To review the role of prostacyclin and explore future anticoagulation strategies.

Summary:

  • This review examines biocompatibility in hemodialysis, focusing on membrane effects on coagulation, fibrinolysis, and complement/kallikrein cascades.

Related Experiment Videos

  • It highlights platelet activation's impact on the coagulation system and dialytic efficiency.
  • The continuous infusion of epoprostenol sodium salt (prostacyclin) in hemodialysis is described, alongside future anticoagulation perspectives.

    • Impact:

    • Provides a comprehensive overview of hemodialysis biocompatibility and its clinical relevance.
    • Informs strategies for optimizing anticoagulation and minimizing adverse events during dialysis.
    • Guides future research in developing more biocompatible materials and anticoagulation protocols.